Literature DB >> 8213806

Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature.

B N Becker1, P Fall, C Hall, D Milam, J Leonard, A Glick, G Schulman.   

Abstract

Acyclovir nephrotoxicity has been described since the inception of the drug's use more than a decade ago. Acute renal failure mediated by this compound is characterized by abrupt elevations in serum creatinine and a gradual return to baseline renal function on discontinuation of the drug. Drug crystal formation in collecting tubules resulting in an intraparenchymal form of obstructive nephropathy has been suggested as the mechanism for acyclovir nephrotoxicity. The patient we present developed rapidly progressive acute renal failure with concomitant mental status changes in the setting of treatment with high-dose parenteral acyclovir. Acyclovir therapy was discontinued and an open renal biopsy was obtained to further evaluate our patient's diminishing renal function. Pathologic examination of the biopsy specimen revealed loss of proximal tubule brush border and dilated proximal and distal tubules with flattening of lining cells and focal nuclear loss. No crystals were noted. These changes were consistent with acute tubular necrosis with regeneration. Over the next 4 days our patient's renal and neurologic levels recovered to their prehospitalization statuses. It appears that our patient was affected by acyclovir-mediated nephrotoxicity that manifested on biopsy by acute tubular necrosis and the absence of crystalluria or crystal deposition. Intravenous acyclovir treatment can therefore produce rapidly progressive acute neurologic and renal toxicity that is usually reversible. The pathologic changes of acute tubular necrosis must now be included as part of the spectrum of renal damage associated with acyclovir therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213806     DOI: 10.1016/s0272-6386(12)80939-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con.

Authors:  G Chanques; S Jaber
Journal:  Intensive Care Med       Date:  2014-11-01       Impact factor: 17.440

2.  Acute kidney injury due to acyclovir.

Authors:  Cigdem Yildiz; Yasemin Ozsurekci; Safak Gucer; Ali Bulent Cengiz; Rezan Topaloglu
Journal:  CEN Case Rep       Date:  2012-10-01

3.  Impact of a Rapid Herpes Simplex Virus PCR Assay on Duration of Acyclovir Therapy.

Authors:  Tam T Van; Kanokporn Mongkolrattanothai; Melissa Arevalo; Maryann Lustestica; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

Review 4.  Update on Herpes simplex keratitis management.

Authors:  Daniel Sibley; Daniel F P Larkin
Journal:  Eye (Lond)       Date:  2020-08-25       Impact factor: 3.775

5.  The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.

Authors:  Marion Pierson-Marchandise; Valérie Gras; Julien Moragny; Joelle Micallef; Louise Gaboriau; Sylvie Picard; Gabriel Choukroun; Kamel Masmoudi; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2017-03-14       Impact factor: 4.335

6.  Acute renal injury induced by valacyclovir hydrochloride: A case report.

Authors:  Yanning Zhang; Yuxi Cong; Yan Teng
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

Review 7.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

Review 8.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 9.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Oral acyclovir induced acute renal failure.

Authors:  Jian-Biao Meng; Xia Zheng; Gen Zhang; Qiang Fang
Journal:  World J Emerg Med       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.